DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 017489
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
NDA 017489 describes ORTHO-NOVUM 1/35-21, which is a drug marketed by Ortho Mcneil Pharm and is included in one NDA. Additional details are available on the ORTHO-NOVUM 1/35-21 profile page.
The generic ingredient in ORTHO-NOVUM 1/35-21 is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
The generic ingredient in ORTHO-NOVUM 1/35-21 is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
Summary for 017489
| Tradename: | ORTHO-NOVUM 1/35-21 |
| Applicant: | Ortho Mcneil Pharm |
| Ingredient: | ethinyl estradiol; norethindrone |
| Patents: | 0 |
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL-21 | Strength | 0.035MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
